Table 2.

Treatment and covariate effects on unfavourable outcome for men (N = 974)

	r/n	OR (unadjusted), 95% CI	p	aOR (adjusted), 95% CI	p
Treatment
HRZE	30/326 (33)			1.0
2MHRZ/2MHR	55/312 (32)	2.22 (1.36–3.62)	0.001	2.24 (1.37–3.65)	0.001
2EMRZ/2MR	78/336 (35)	3.31 (2.07–5.29)	< 0.001	3.31 (2.07–5.28)	< 0.001
Age
≤ 30 years	58/435	1.0		1.0
> 30 years	105/539	1.46 (1.00–2.12)	0.045	1.48 (1.02–2.14)	0.037
BMI
< 18.5	105/547	1.0		1.0
≥ 18.5	58/427	0.65 (0.45–0.93)	0.020	0.64 (0.44–0.92)	0.017
Race
Asian	50/311	1.0
Black	70/430	0.85 (0.55–1.32)	0.469	–	–
Mixed race and Caucasian	43/233	0.97 (0.58–1.61)	0.902
Smoking
Never smoked	39/334	1.0		1.0
Ever smoked	124/640	1.61 (1.04–2.49)	0.034	1.60 (1.07–2.40)	0.023
HIV
Negative	143/922 (95)	1.0		1.0
Positive	20/52	4.26 (2.22–8.18)	< 0.001	3.97 (2.12–7.42)	< 0.001
Cavities
No cavities	16/198	1.0		1.0
Cavities	147/776	2.78 (1.59–4.85)	< 0.001	2.78 (1.59–4.84)	< 0.001

r number with unfavourable outcome

n total in category